Clinical Trial Update: Dose Escalation Study of AST-OPC1 in Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-escalation trial of AST-OPC1 in spinal cord injury has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Spinal Cord Injury
• Spinal Cord Trauma
• Spine Injury

Drugs mentioned

• AST-OPC1

Snippet

Sponsor: Lineage Cell Therapeutics, Inc. | Conditions: Cervical Spinal Cord Injury, Spine Injury | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-13